EMPERY ASSET MANAGEMENT, LP 13D and 13G filings for EyeGate Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2021-08-20 4:40 pm Purchase |
2021-08-09 | 13G | EyeGate Pharmaceuticals, Inc. EYEG |
EMPERY ASSET MANAGEMENT, LP | 868,622 6.880% |
868,622 (New Position) |
Filing |